Merchant; Mark

Patent Applications and Registrations

Patent applications and USPTO patent grants for Merchant; Mark.The latest application filed is for "combination therapy for cancer comprising pd-1 axis binding antagonist and il6 antagonist".

Company Profile

1.4.12

Merchant; Mark - South San Francisco CA
Merchant; Mark - Belmont CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Therapy For Cancer Comprising Pd-1 Axis Binding Antagonist And Il6 Antagonist App 20210332143 - Huseni; Mahrukh ; et al.	2021-10-28
Combination Of Bcl-2 Inhibitor And Mek Inhibitor For The Treatment Of Cancer App 20210169865 - Merchant; Mark ; et al.	2021-06-10
Combination of Bcl-2 inhibitor and MEK inhibitor for the treatment of cancer Grant 10,959,993 - Merchant , et al. March 30, 2	2021-03-30
Combination Of Bcl-2 Inhibitor And Mek Inhibitor For The Treatment Of Cancer App 20180303815 - Merchant; Mark ; et al.	2018-10-25
Use of a combination of a MEK inhibitor and an ERK inhibitor for treatment of hyperproliferative diseases Grant 9,532,987 - Belvin , et al. January 3, 2	2017-01-03
Combination Therapy With C-met And Egfr Antagonists App 20160303127 - FILVAROFF; Ellen ; et al.	2016-10-20
Combinations of AKT inhibitor compounds and vemurafenib, and methods of use Grant 9,150,548 - Hoeflich , et al. October 6, 2	2015-10-06
Combination Treatments Comprising C-met Antagonists And B-raf Antagonists App 20150125452 - Wilson; Timothy R. ; et al.	2015-05-07
Use Of A Combination Of A Mek Inhibitor And An Erk Inhibitor For Treatment Of Hyperproliferative Diseases App 20150111869 - Belvin; Marcia ; et al.	2015-04-23
Combination Therapy With C-met And Egfr Antagonists App 20150056207 - Filvaroff; Ellen ; et al.	2015-02-26
Combinations Of Akt Inhibitor Compounds And Vemurafenib, And Methods Of Use App 20140275106 - Hoeflich; Klaus ; et al.	2014-09-18
Combination Treatments Comprising C-met Antagonists And B-raf Antagonists App 20130078252 - Wilson; Timothy R. ; et al.	2013-03-28
Treatment Method App 20110262436 - Bender; Brendan C. ; et al.	2011-10-27
Combination Therapy With C-met And Egfr Antagonists App 20090226443 - Filvaroff; Ellen ; et al.	2009-09-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.